SCHEMBL3703392

SCHEMBL3703392

C=Cc1cc(O)c(O)c(OC)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.63
EGFR P00533 4/20 0.56
MAPT P10636 3/20 0.56
KMT2A Q03164 3/20 0.56
CYP3A4 P08684 3/20 0.56
ALDH1A1 P00352 3/20 0.56
HPGD P15428 3/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2C9 P11712 2/20 0.56
NFKB1 P19838 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 2/20 0.56
LMNA P02545 2/20 0.56
BLM P54132 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
RGS12 O14924 1/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
ALOX15 P16050 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6443870 0.91 TRPA1 (0.62) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL727024 0.91 TRPA1 (0.62) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL18116476 0.84 EGFR (0.58) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL12203362 0.84 ESR1 (0.60) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL24110743 0.82 TRPA1 (0.58) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL29696089 0.82 APP (0.59) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL22991659 0.82 APP (0.59) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL151119 0.80 TUBB1 (0.59) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL3847926 0.80 TUBB1 (0.59) TRPA1EGFRMAPTKMT2ACYP3A4
SCHEMBL22917545 0.80 ERN1 (0.62) TRPA1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3645492-B1 PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS UNIV LEUVEN KATH (BE) 2024-08-21 EP claimed
CN-110809570-B Preparation method of ortho-alkoxy bisphenol monomer 鲁汶天主教大学 2023-06-23 CN claimed
US-11414519-B2 Ortho alkoxy bisphenol monomers KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-08-16 US claimed
EP-3645492-A1 PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS Katholieke Universiteit Leuven (BE) 2020-05-06 EP claimed
US-20200123315-A1 ORTHO ALKOXY BISPHENOL MONOMERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2020-04-23 US claimed
CN-110809570-A Preparation method of ortho-alkoxy bisphenol monomer 鲁汶天主教大学 2020-02-18 CN claimed
WO-2019002503-A1 PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2019-01-03 WO claimed
EP-4455188-A2 PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2024-10-30 EP disclosed
EP-3645492-B1 PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS UNIV LEUVEN KATH (BE) 2024-08-21 EP disclosed
CN-110809570-B Preparation method of ortho-alkoxy bisphenol monomer 鲁汶天主教大学 2023-06-23 CN disclosed
US-11414519-B2 Ortho alkoxy bisphenol monomers KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-08-16 US disclosed
US-11234975-B2 Levorphanol prodrugs and processes for making and using them KEMPHARM, INC. (US) 2022-02-01 US disclosed
US-20210002226-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2021-01-07 US disclosed
US-9850252-B2 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof KEMPHARM, INC. (US) 2017-12-26 US disclosed
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2017-11-02 US disclosed
US-20170049765-A1 Methylphenidate-Prodrugs, Processes of Making and Using the Same COMMAVE THERAPEUTICS SA (CH) 2017-02-23 US disclosed
EP-2453311-B1 Toner for developing electrostatic image and manufacturing method of toner for developing electrostatic image KONICA MINOLTA BUSINESS TECH (JP) 2013-12-25 EP disclosed
CN-102540791-B Toner for developing electrostatic image and manufacturing method of toner for developing electrostatic image KONICA MINOLTA BUSINESS TECH 2013-10-16 CN disclosed
CN-102540791-A Toner for developing electrostatic image and manufacturing method of toner for developing electrostatic image KONICA MINOLTA BUSINESS TECH 2012-07-04 CN disclosed
EP-2453311-A1 Toner for developing electrostatic image and manufacturing method of toner for developing electrostatic image Konica Minolta Business Technologies, Inc. (JP) 2012-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 TRPA1 2443/4885EGFR 2553/4885MAPT 2959/4885
US-20170049765-A1 Methylphenidate-Prodrugs, Processes of Making and Using the Same COMT, TPMT, PNMT TRPA1 4133/4885EGFR 2414/4885MAPT 406/4885
US-11234975-B2 Levorphanol prodrugs and processes for making and using them OPRM1, OPRL1, OPRK1 TRPA1 3428/4885EGFR 4271/4885MAPT 2539/4885
US-11414519-B2 Ortho alkoxy bisphenol monomers ALK, ESR1, ADIPOR1 TRPA1 234/4885EGFR 3523/4885MAPT 180/4885
US-20210002226-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRK1, OPRD1 TRPA1 3204/4885EGFR 4498/4885MAPT 2545/4885
US-20200123315-A1 ORTHO ALKOXY BISPHENOL MONOMERS ALK, ESR1, ADIPOR1 TRPA1 234/4885EGFR 3523/4885MAPT 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.